SL-GD002
/ JY Biomed, SL Science Holding Limited
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 23, 2026
Clinical study of the exosome nasal spray GD002 in the treatment of Infantile Epileptic Spasms Syndrome
(ChiCTR)
- P=N/A | N=36 | Recruiting | Sponsor: The First Medical Centre, Chinese PLA General Hospital; The First Medical Centre, Chinese PLA General Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Epilepsy
1 to 1
Of
1
Go to page
1